Recurrence of Hepatocellular Carcinoma

Risk Factors for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01520779

Enrollment

Registered

2012-01-30

Start date

2012-01-31

Completion date

2012-12-31

Last updated

2013-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

Hepatocellular cacinoma, Radiofrequancy ablation, Intrahepatic recurrence

Brief summary

analysis of the risk factors of intra-hepatic distant recurrence (IDR) of hepatocellular carcinoma within 1 year after radiofrequency ablation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

1. Proved diagnosis of HCC according to AASLD practice guidelines (Bruix and Sherman, 2005). 2. Patients underwent RFA for HCC with BCLC (The Barcelona-Clinic- Liver-Cancer staging system) stage A (Bruix and Sherman, 2005) with no eligibility or ability to do transplantation or resection. 3. Patients should be followed-up for more than 12 months to exclude early recurrence i.e. recurrence within 1 year. 4. Patients with INR \< 1.5 or prothrombin concentration \> 50%. 5. Platelet count \> 50000 cell/mm3.

Exclusion criteria

1. Presence of extra-hepatic metastasis or gross vascular invasion. 2. Child class C patients. 3. Follow up period of less than 12 months.

Design outcomes

Primary

Measure	Time frame
Recurrence of hepatocellular carcinoma	1 year

Countries

Egypt

Outcome results